CAPITOL HILL CONSULTING GROUP for ASTELLAS PHARMA US
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Pharmaceutical and life sciences, including but not limited to: The Federal Food, Drug and Costmetic Act; Coverage and reimbursement issues under the Medicare and Medicaid programs; Drug importation; Follow-on biologics (i.e., the Pharmaceutical Biologics Price Competition and Innovation Act of 2007); federal organ transplant and anti-infectives policy
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMANDA HILL New | — |
| STEVEN E IRIZARRY New | — |
Medicare/Medicaid MMM
Pharmaceutical and life sciences, including but not limited to: The Federal Food, Drug and Costmetic Act; Coverage and reimbursement issues under the Medicare and Medicaid programs; Drug importation; Follow-on biologics (i.e., the Pharmaceutical Biologics Price Competition and Innovation Act of 2007); federal organ transplant and anti-infectives policy
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMANDA HILL New | — |
| STEVEN E IRIZARRY New | — |
Health Issues HCR
Pharmaceutical and life sciences, including but not limited to: The Federal Food, Drug and Costmetic Act; Coverage and reimbursement issues under the Medicare and Medicaid programs; Drug importation; Follow-on biologics (i.e., the Pharmaceutical Biologics Price Competition and Innovation Act of 2007); federal organ transplant and anti-infectives policy
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMANDA HILL New | — |
| STEVEN E IRIZARRY New | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| ASTELLAS PHARMA, INC. | Japan | Japan | 99.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.